Stockreport

How Recent Shifts Are Reframing The Biocon (NSEI:BIOCON) Investment Narrative [Yahoo! Finance]

Bio-Rad Laboratories, Inc. Class B  (BIO.B) 
PDF Biocon's fair value estimate has been adjusted slightly, moving from ?421.60 to ?420.74, a change of less than 1% that keeps the price target broadly in line with earli [Read more]